Posted on 4/3/20
Merrimack Divests Early Stage Asset for $2.25M; Provides Strategy Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced receipt of $2.25 million in connection with the closing of a transaction in which the Company sold . . .
Posted on 4/2/20
Voltron Therapeutics Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital
Voltron Therapeutics, Inc. announced today that it has entered into a Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital . . .
Posted on 4/2/20
Phio Pharmaceuticals Closes $4M Registered Direct Offering
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 4/2/20
Americares Receives Over $500,000 Donation from UBS Optimus Foundation to Support COVID-19 Response Efforts
Americares health workers in La Guajira, Colombia, wear protective gear while treating patients during the COVID-19 pandemic. (Photo courtesy of Americares)UBS Optimus Foundation has donated over . . .
Posted on 4/1/20
Bioasis Announces Shares for Debt Transaction
GUILFORD, Conn.--(BUSINESS WIRE)--Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) . . .
Posted on 4/1/20
908 Devices and Transcenta Expand Joint Innovation Partnership
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced an expansion of their joint innovation partnership with Transcenta, a fully integrated . . .
Posted on 4/1/20
Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the achievement of key milestones . . .
Posted on 3/31/20
Phio Pharmaceuticals Announces $4.0M Registered Direct Offering
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 3/31/20
Kleo Pharmaceuticals Enters into Research Collaboration with Green Cross LabCell
Kleo Pharmaceuticals, Inc., a leading company in the field of developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced . . .
Posted on 3/31/20
VBI Vaccines Announces Collaboration with the National Research Council of Canada
CAMBRIDGE, Mass. & OTTAWA, Ontario--(BUSINESS WIRE)--VBI Vaccines Inc. (NASDAQ: VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with . . .
Posted on 3/31/20
State Economies Most Exposed to Coronavirus – WalletHub Study
Coronavirus isn’t just a danger to Americans’ health. It’s also a menace to our wallets. It’s led to the closing of scores of non-essential events and . . .
Posted on 3/31/20
Cigna and Humana Join Aetna in Waiving COVID-19 Patients' Cost-Sharing Payments
Heath insurers Cigna (NYSE:CI) and Humana (NYSE:HUM) are waiving co-payments and cost-sharing for patients with COVID-19, the disease caused by the new coronavirus. CVS Health's (NYSE:CVS) . . .
Posted on 3/30/20
Exicure Provides Business Update Amid COVID-19 Pandemic
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today provided an update on . . .
Posted on 3/30/20
NeuroBo Pharmaceuticals Provides Corporate Strategic Update
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results . . .
Posted on 3/30/20
Planet Fitness Provides Business Update in Response to COVID-19
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing global franchisors and operators of fitness centers with more members than any other fitness brand, . . .
Posted on 3/30/20
Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines called Synthetic Biotic medicines, today provided an . . .
Posted on 3/30/20
Charles River Laboratories and Deciphex Form a Partnership
WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical . . .
Posted on 3/30/20
Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform
CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Generation Bio and Vir Biotechnology (Nasdaq: VIR) today announced a collaborative research agreement to explore the potential for Generation Bio’s non-viral gene . . .
Posted on 3/30/20
Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results
CAMBRIDGE, Mass., March 30, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported recent . . .
Posted on 3/30/20
Berkshire Hathaway Shares Declining To Book Value
SummaryBerkshire Hathaway shares have sunk to the most recent book value figures.Shares trading this close to book value is a truly rare event, taking place only . . .
Posted on 3/30/20
Vertex Pharmaceuticals to Pause Some Clinical Trials
Vertex Pharmaceuticals (NASDAQ:VRTX), the company behind the only drugs that treat the root cause of cystic fibrosis, stated on Friday that its operations are holding up . . .
Posted on 3/30/20
Will Warren Buffett Buy an Airline? Or Is He Looking to Sell?
In late 2016, investors were shocked to learn that Warren Buffett's Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) had invested in the four largest U.S. airlines: American Airlines (NASDAQ:AAL), . . .
Posted on 3/29/20
University of South Florida Health, Northwell Health, Formlabs and Tampa General Hospital Join Forces
The University of South Florida (USF) Health, Formlabs, a leading 3D printing company, and Northwell Health, New York's largest healthcare provider, today announced they have successfully . . .
Posted on 3/29/20
Translate Bio Provides MRT5005 Program Updates
LEXINGTON, Mass., March 26, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Posted on 3/29/20
Sanofi Pasteur and Translate Bio to Collaborate
PARIS and LEXINGTON, Mass., March 27, 2020 (GLOBE NEWSWIRE) -- Sanofi Pasteur, the vaccines global business unit of Sanofi (EURONEXT: SAN and NASDAQ: SNY), and Translate . . .

